Markets:

Overview

News

Currencies

International

Treasuries

Tenax Therapeutics, Inc. - Common Stock (NQ:TENX)

12.90 -0.10 (-0.77%)

Streaming Delayed Price Updated: 3:16 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tenax Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 14, 2022

Gainers Sigilon Therapeutics (NASDAQ:SGTX) stock rose 15.5% to $1.49 during Monday's after-market session. The market value of their outstanding shares is at $48.1 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 28, 2022

On Monday morning, 66 companies achieved new lows for the year. Noteable 52-Week Lows: Gilead Sciences (NASDAQ:GILD) was the largest firm on a market cap basis to set a...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 08, 2022

Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a...

Via Benzinga

NASDAQ:TENX Shareholder Alert: Investigation over Potential Wrongdoing at Tenax Therapeutics, Inc. ↗

February 17, 2022

San Diego, CA -- (SBWIRE) -- 02/17/2022 -- Certain directors of Tenax Therapeutics, Inc. are under investigation concerning potential breaches of fiduciary duties .

Via SBWire

Stocks That Hit 52-Week Lows On Friday ↗

January 14, 2022

During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

January 06, 2022

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this...

Via Benzinga

Investigation for Investors in Tenax Therapeutics, Inc. (NASDAQ:TENX) Shares Announced ↗

December 13, 2021

San Diego, CA -- (SBWIRE) -- 12/13/2021 -- An investigation was announced for investors of Tenax Therapeutics, Inc. (NASDAQ:TENX) shares over potential securities laws violations by Tenax Therapeutics,...

Via SBWire

NASDAQ:TENX Investor Notice: Investigation over Potential Wrongdoing at Tenax Therapeutics, Inc. ↗

December 01, 2021

San Diego, CA -- (SBWIRE) -- 12/01/2021 -- Certain directors of Tenax Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties.

Via SBWire

Tenax Therapeutics Reports Third Quarter 2021 Results and Provides Business Update

November 16, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

NASDAQ:TENX Investor Notice: Investigation over Possible Securities Laws Violations by Tenax Therapeutics, Inc. ↗

November 09, 2021

San Diego, CA -- (SBWIRE) -- 11/09/2021 -- Tenax Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Tenax Therapeutics Announces Clearance of the Investigational New Drug Application for Imatinib in Pulmonary Arterial Hypertension (PAH)

October 06, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

Tenax Therapeutics to Present at the Benzinga Healthcare Small Cap Conference

September 28, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

Tenax Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 09, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

Tenax Therapeutics Reports Second Quarter 2021 Results and Provides Business Update

August 17, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

Tenax Announces New Publication Highlighting Novel Levosimendan Mechanism of Action in Pulmonary Hypertension Patients with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

August 12, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

Tenax Therapeutics Announced KOL Webinar on Levosimendan for Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

August 05, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

Tenax Therapeutics Announces CEO Transition and $10 Million PIPE Offering Priced At-the-Market under Nasdaq Rules

July 07, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

25 Stocks Moving in Thursday's Pre-Market Session ↗

June 24, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) rose 43.3% to $2.45 in pre-market trading after the company announced it has added the ability to manage Instacart Ads to its...

Via Benzinga

45 Biggest Movers From Yesterday ↗

June 24, 2021

Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613. First...

Via Benzinga

31 Stocks Moving In Wednesday's Mid-Day Session ↗

June 23, 2021

Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613. Orphazyme A/S (NASDAQ: ORPH)...

Via Benzinga

26 Stocks Moving in Wednesday's Pre-Market Session ↗

June 23, 2021

Gainers Acasti Pharma Inc. (NASDAQ: ACST) rose 39% to $0.75 in pre-market trading after jumping 10% on Tuesday. The company reported a narrower FY21 loss. SeaChange International...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 22, 2021

Gainers Tenax Therapeutics (NASDAQ:TENX) ...

Via Benzinga

Tenax Therapeutics Set to Join Russell Microcap® Index

June 10, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

Tenax Therapeutics Reports First Quarter 2021 Results and Provides Business Update

May 17, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

Tenax Announces Publication Titled “Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial ”

April 09, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders

April 07, 2021

From Tenax Therapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Tenax Therapeutics, Inc. - Common Stock (NQ:TENX)

All News about Tenax Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today